New Key Statistics Module, Z-Score and F-Score
SHSE:603229 Key Ratios
Market Cap ¥ M | 7,505.89 |
Enterprise Value ¥ M | 6,841.67 |
P/E(ttm) | 28.52 |
PE Ratio without NRI | 27.31 |
Forward PE Ratio | 21.52 |
Price/Book | 3.28 |
Price/Sales | 8.80 |
Price/Free Cash Flow | 53.82 |
Price/Owner Earnings | 75.30 |
Payout Ratio % | 0.39 |
Revenue (TTM) ¥ M | 835.00 |
EPS (TTM) ¥ | 0.32 |
Beneish M-Score | -2.48 |
10-y EBITDA Growth Rate % | 7.90 |
5-y EBITDA Growth Rate % | 37.60 |
y-y EBITDA Growth Rate % | 8.50 |
EV-to-EBIT | 22.55 |
EV-to-EBITDA | 22.55 |
PEG | 0.73 |
Shares Outstanding M | 830.30 |
Net Margin (%) | 30.84 |
Operating Margin % | 35.05 |
Pre-tax Margin (%) | 35.41 |
Quick Ratio | 2.00 |
Current Ratio | 2.53 |
ROA % (ttm) | 8.60 |
ROE % (ttm) | 11.57 |
ROIC % (ttm) | 16.13 |
Dividend Yield % | 1.43 |
Altman Z-Score | 7.88 |
SHSE:603229 Number of Guru Trades
SHSE:603229 Volume of Guru Trades
Gurus Latest Trades with SHSE:603229
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603229 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Ausun Pharmaceutical Co Ltd Insider Transactions
No Available Data